Why is Solara Active falling/rising?
2025-12-04 01:03:51Recent Price Movement and Market Context Solara Active’s shares have gained momentum over the past three days, delivering a cumulative return of 7.98% during this period. On 03-Dec, the stock outperformed its sector by 5.76%, reaching an intraday high of ₹580.9, representing a 10.73% surge from the previous close. The stock traded within a wide range of ₹55.9, indicating heightened volatility and active trading interest. However, the weighted average price suggests that a larger volume of shares exchanged hands closer to the day’s lower price levels, hinting at some selling pressure despite the overall price rise. While the stock’s price is currently above its 5-day moving average, it remains below its 20-day, 50-day, 100-day, and 200-day moving averages. This technica...
Read More
Solara Active Pharma Sciences Hits Intraday High with Strong Trading Momentum
2025-12-03 12:22:28Solara Active Pharma Sciences recorded a robust intraday performance today, reaching a high of Rs 580.9, reflecting a 10.73% rise during the session. The stock outpaced its sector and broader market indices, demonstrating notable volatility and sustained gains over recent days.
Read More
Solara Active Pharma Sciences Faces Technical Momentum Shift Amid Mixed Market Signals
2025-12-03 08:08:25Solara Active Pharma Sciences has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. The stock’s recent price movements and technical parameters suggest a transition from a sideways trend to a mildly bearish stance, prompting a closer examination of its market dynamics within the Pharmaceuticals & Biotechnology sector.
Read More
Solara Active Pharma Sciences: Technical Momentum and Market Assessment Update
2025-12-02 08:11:38Solara Active Pharma Sciences has experienced a notable shift in its technical momentum, reflecting a transition from a mildly bearish stance to a more sideways trend. This development comes amid mixed signals from key technical indicators such as MACD, RSI, and moving averages, highlighting a complex market assessment for the pharmaceutical and biotechnology company.
Read More
Solara Active Pharma Sciences Faces Mixed Signals Amid Market and Financial Challenges
2025-11-25 08:58:42Solara Active Pharma Sciences has experienced a shift in market assessment following recent developments across technical indicators, valuation metrics, financial trends, and overall quality parameters. The pharmaceutical company’s stock performance and financial results reveal a complex picture that investors should carefully analyse.
Read MoreHow has been the historical performance of Solara Active?
2025-11-24 23:25:44Revenue and Operating Performance Trends Over the seven-year period ending March 2025, Solara Active's net sales exhibited variability, peaking at ₹1,616.88 crores in March 2021 before declining to ₹1,283.76 crores by March 2025. The total operating income mirrored this trend, with a high in 2021 and a gradual decrease thereafter. Raw material costs, a significant expense component, fluctuated notably, reaching a low in 2025 at ₹581.66 crores compared to ₹858.86 crores in 2022, reflecting possible operational adjustments or cost efficiencies. Employee costs steadily increased from ₹185.81 crores in 2019 to ₹211.69 crores in 2025, indicating investment in human resources despite revenue pressures. Other expenses remained relatively stable, hovering around ₹239 to ₹335 c...
Read MoreIs Solara Active technically bullish or bearish?
2025-11-20 08:12:53As of 19 November 2025, the technical trend for Solara Active has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD and Bollinger Bands both indicating bearish conditions, along with a mildly bearish KST and OBV on the weekly timeframe. The monthly indicators also reflect a mildly bearish sentiment, with the MACD and Dow Theory confirming this outlook. The daily moving averages are mildly bullish, but this is not enough to offset the overall bearish trend observed in the longer time frames....
Read More
Solara Active Pharma Sciences Technical Momentum Shifts Amid Market Volatility
2025-11-20 08:08:24Solara Active Pharma Sciences has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent evaluation adjustments highlight a transition from a sideways trend to a mildly bearish stance, underscoring the importance of technical indicators such as MACD, RSI, and moving averages in assessing the stock’s near-term trajectory.
Read MoreIs Solara Active technically bullish or bearish?
2025-11-19 08:16:54As of 18 November 2025, the technical trend for Solara Active has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different time frames. The weekly MACD is bearish, while the monthly MACD is bullish, indicating conflicting momentum. The weekly RSI shows no signal, and both the weekly and monthly Bollinger Bands are bearish, suggesting potential downward pressure. Daily moving averages are mildly bullish, providing some support. The KST is mildly bearish on both weekly and monthly charts, and Dow Theory indicates no trend weekly but is mildly bearish monthly. Overall, the indicators reflect a lack of clear direction, leading to a neutral stance....
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30-Jan-2026 | Source : BSESolara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Friday February 06 2026 to discuss the Companys unaudited financial results for the quarter ended December 31 2025
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended December 31 2025.
30-Jan-2026 | Source : BSESolara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSECertificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.
Corporate Actions
No Upcoming Board Meetings
Solara Active Pharma Sciences Ltd has declared 30% dividend, ex-date: 18 Aug 21
No Splits history available
No Bonus history available
Solara Active Pharma Sciences Ltd has announced 1:3 rights issue, ex-date: 15 May 24